B

Bolt Biotherapeutics
D

BOLT

0.62260
USD
-0.04
(-5.67%)
مغلق
حجم التداول
1
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
23,823,691
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
الأخبار
المقالات

العنوان: Bolt Biotherapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.